“MDLs Make Up More Than Half of U.S. Cases, Whether It's 65% or 71%,” Law.com
Gary Feldon of Hollingsworth LLP was interviewed for this story.
Gary Feldon of Hollingsworth LLP was interviewed for this story.
Hollingsworth LLP's Gary Feldon represents clients in high-stakes, complex civil litigation, including in pharmaceutical and medical device, toxic tort, and products liability matters.
Eric Lasker served as Editor of a comprehensive federal Circuit-by-Circuit guide providing a quick reference that will help relegate this wayward caselaw to the dustbin of legal history and clear the field for the proper application of Rule 702 moving forward.
Managing Partner Donald R. McMinn discusses the importance of being a litigation firm that tries cases and lets litigators litigate in order to best advance clients’ interests.
Eric Lasker and Elyse Shimada will speak on July 30, 2024 | 1:00pm-2:30pm EDT. The panel presentation will be followed by a live Q&A.
Matthew Malinowski, Gary Feldon, and Sebastian Ovalle say a new wave of PFAS litigation has begun; if it gains momentum, it could be the biggest yet.
Firm partners Gary Feldon, Matthew Malinowski, and Sebastian Ovalle analyze the impact of the end of Chevron deference.
Clients praise the firm for its finely honed expertise and successful outcomes in the litigation space.
By Andrew Reissaus and Aleksandra Rybicki
A Cook County, Illinois jury returned a verdict in favor of Firm clients Sterigenics and Sotera Health, LLC after a twenty-eight day trial involving a plaintiff’s claims that emissions of ethylene oxide from Sterigenics medical-device sterilization…